CymaBay Therapeutics Free Cash Flow (Quarterly) Trends

CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)

32.48 0.00 (0.00%) USD | NASDAQ | Mar 25, 16:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-27.56M
September 30, 2023	-26.14M
June 30, 2023	-25.51M
March 31, 2023	6.236M
December 31, 2022	-18.77M
September 30, 2022	-17.53M
June 30, 2022	-22.56M
March 31, 2022	-25.36M
December 31, 2021	-14.24M
September 30, 2021	-15.41M
June 30, 2021	-19.21M
March 31, 2021	-20.66M
December 31, 2020	-14.82M
September 30, 2020	-7.473M
June 30, 2020	-7.749M
March 31, 2020	-14.71M
December 31, 2019	-28.16M
September 30, 2019	-23.15M
June 30, 2019	-24.34M
March 31, 2019	-22.57M
December 31, 2018	-20.06M
September 30, 2018	-16.09M

Date	Value
June 30, 2018	-12.82M
March 31, 2018	-6.487M
December 31, 2017	-6.072M
September 30, 2017	-5.466M
June 30, 2017	-5.891M
March 31, 2017	-2.203M
December 31, 2016	-5.402M
September 30, 2016	-5.746M
June 30, 2016	-6.107M
March 31, 2016	-6.14M
December 31, 2015	-5.196M
September 30, 2015	-6.66M
June 30, 2015	-5.309M
March 31, 2015	-6.159M
December 31, 2014	-7.472M
September 30, 2014	-3.902M
June 30, 2014	-4.80M
March 31, 2014	-5.043M
December 31, 2013	-3.537M
September 30, 2013	-0.601M
June 30, 2013	-2.161M
March 31, 2013	-2.159M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-28.16M

Minimum

Dec 2019

6.236M

Maximum

Mar 2023

-18.27M

Average

-19.21M

Median

Jun 2021

Free Cash Flow (Quarterly) Benchmarks